Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry

Virus Research

Volumn 121, Issue 2, 2006, Pages 205-214

  Mpanju, Onesmo M ^a   Towner, Jonathan S ^b   Dover, Jason E ^b   Nichol, Stuart T ^b   Wilson, Carolyn A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Ebolavirus; Filovirus; Glycoprotein; Mutagenesis; Viral entry

Indexed keywords

ALANINE; AMINO ACID; MUTANT PROTEIN; PHENYLALANINE; RETROVIRUS VECTOR; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; EBOLA VIRUS; EMBRYO; FILOVIRUS; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; VIRUS INFECTION; VIRUS STRAIN; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MOLECULAR SEQUENCE DATA; PHENYLALANINE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

COTE D'IVOIRE EBOLAVIRUS; EBOLA VIRUS; MARBURGVIRUS; ZAIRE EBOLAVIRUS;

EID: 33749133853     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.06.002     Document Type: Article

References (30)

1. Feldmann H., Klenk H.D., and Sanchez A. Molecular biology and evolution of filoviruses. Arch. Virol. Suppl. 7 (1993) 81-100
2. Feldmann H., Nichol S.T., Klenk H.D., Peters C.J., and Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199 (1994) 469-473
3. Feldmann H., Volchkov V.E., Volchkova V.A., and Klenk H.D. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch. Virol. Suppl. 15 (1999) 159-169
4. Finer M.H., Dull T.J., Qin L., Farson D., and Roberts M.R. Kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83 1 (1994) 43-50
5. Jeffers S.A., Sanders D.A., and Sanchez A. Covalent modifications of the ebola virus glycoprotein. J. Virol. 76 (2002) 12463-12472
6. Jones S.M., Feldmann H., Stroher U., Geisbert J.B., Fernando L., Grolla A., Klenk H.D., Sullivan N.J., Volchkov V.E., Fritz E.A., Daddario K.M., Hensley L.E., Jahrling P.B., and Geisbert T.W. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11 (2005) 786-790
7. Malashkevich V.N., Schneider B.J., McNally M.L., Milhollen M.A., Pang J.X., and Kim P.S. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proceedings of the National Academy of Sciences of the United States of America, vol. 96 (1999) 2662-2667
8. Manicassamy B., Wang J., Jiang H., and Rong L. Comprehensive analysis of ebola virus GP1 in viral entry. J. Virol. 79 (2005) 4793-4805
9. Medina M.F., Kobinger G.P., Rux J., Gasmi M., Looney D.J., Bates P., and Wilson J.M. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol. Ther. J. Am. Soc. Gene Ther. 8 (2003) 777-789
10. Neumann G., Feldmann H., Watanabe S., Lukashevich I., and Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J. Virol. 76 (2002) 406-410
11. Neumann G., Feldmann H., Watanabe S., Lukashevich I., and Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J. Virol. 76 1 (2002) 406-410
12. Sanchez A., Khan A.S., Zaki S., Nabel E.G., Ksiazek T.G., and Peters C. Fields virology. In: Straus S.E. (Ed). Fields Virology. fourth ed. (2001), Lippincott Williams & Wilkins, Philadelphia 1285-1286
13. Sanchez A., Kiley M.P., Holloway B.P., and Auperin D.D. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29 (1993) 215-240
14. Sanchez A., Yang Z.Y., Xu L., Nabel G.J., Crews T., and Peters C.J. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72 (1998) 6442-6447
15. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L., Doms R.W., Bates P., and Pohlmann S. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305 (2003) 115-123
16. Simmons G., Rennekamp A.J., Chai N., Vandenberghe L.H., Riley J.L., and Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J. Virol. 77 (2003) 13433-13438
17. Simmons G., Wool-Lewis R.J., Baribaud F., Netter R.C., and Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. Virol. 76 (2002) 2518-2528
18. Sinn P.L., Hickey M.A., Staber P.D., Dylla D.E., Jeffers S.A., Davidson B.L., Sanders D.A., and McCray Jr. P.B. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. 77 (2003) 5902-5910
19. Sullivan N.J., Peterson M., Yang Z.Y., Kong W.P., Duckers H., Nabel E., and Nabel G.J. Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J. Virol. 79 (2005) 547-553
20. Sullivan N.J., Sanchez A., Rollin P.E., Yang Z.-y., and Nabel G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature (London) 408 (2000) 605-609
21. Takada A., Feldmann H., Stroeher U., Bray M., Watanabe S., Ito H., McGregor M., and Kawaoka Y. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J. Virol. 77 (2003) 1069-1074
22. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., and Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proceedings of the National Academy of Sciences of the United States of America, vol. 94 (1997) 14764-14769
23. Ting Y.T., Wilson C.A., Farrell K.B., Chaudry G.J., and Eiden M.V. Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors. J. Virol. 72 (1998) 9453-9458
24. Towner J.S., Paragas J., Dover J.E., Gupta M., Goldsmith C.S., Huggins J.W., and Nichol S.T. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 332 (2005) 20-27
25. Volchkov V.E., Feldmann H., Volchkova V.A., and Klenk H.D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 5762-5767
26. Watanabe S., Takada A., Watanabe T., Ito H., Kida H., and Kawaoka Y. Functional importance of the coiled-coil of the Ebola virus glycoprotein. J. Virol. 74 (2000) 10194-10201
27. Wilson C.A., and Eiden M.V. Viral and cellular factors governing hamster cell infection by Murine and Gibbon Ape Leukemia viruses. J. Virol. 65 (1991) 5975-5982
28. Wool-Lewis R.J., and Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72 (1998) 3155-3160
29. Wool-Lewis R.J., and Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J. Virol. 73 (1999) 1419-1426
30. Yang Z.-y., Duckers H.J., Sullivan N.J., Sanchez A., Nabel E.G., and Nabel G.J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6 (2000) 886-889